Relation between menin expression and NF-κB activity in an intestinal cell line

Molecular and Cellular Endocrinology

Volumn 291, Issue 1-2, 2008, Pages 109-115

  Theillaumas, Aurélie ^a,b   Blanc, Martine ^a,b   Couderc, Christophe ^a,b   Poncet, Gilles ^a,b   Bazzi, Wissam ^a,b   Bernard, Christine ^a,b   Cordier Bussat, Martine ^a,b   Scoazec, Jean Yves ^a,b   Roche, Colette ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Cyclin D1; Endocrine tumor; Menin; NF B; Proliferation

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHIONINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; INTESTINE CELL; INTESTINE EPITHELIUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

EID: 48449091206     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.05.019     Document Type: Article

References (32)

1. Audard V., Cavard C., Richa H., Infante M., Couvelard A., Sauvanet A., Terris B., Paye F., and Flejou J.F. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas. Pancreas 36 (2008) 80-83
2. Bertolino P., Tong W.M., Galendo D., Wang Z.Q., and Zhang C.X. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol. Endocrinol. 17 (2003) 1880-1892
3. Bhuiyan M.M., Sato M., Murao K., Imachi H., Namihira H., and Takahara J. Expression of menin in parathyroid tumors. J. Clin. Endocrinol. Metab. 85 (2000) 2615-2619
4. Chandrasekaran C., Coopersmith C.M., and Gordon J.I. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. J. Biol. Chem. 271 (1996) 28414-28421
5. Chung D.C., Brown S.B., Graeme-Cook F., Seto M., Warshaw A.L., Jensen R.T., and Arnold A. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J. Clin. Endocrinol. Metab. 85 (2000) 4373-4378
6. Chung D.C. Cyclin D1 in human neuroendocrine tumorigenesis. Ann. NY Acad. Sci. 1014 (2004) 209-217
7. Corbetta S., Vicentini L., Ferrero S., Lania A., Mantovani G., Cordella D., Beck-Peccoz P., and Spada A. Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors. Endocr. Relat. Cancer. 12 (2005) 929-937
8. Dolcet X., Llobet D., Pallares J., and Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows Arch. 446 (2005) 475-482
9. Fu M., Wang C., Li Z., Sakamaki T., and Pestell R.G. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145 (2004) 5439-5447
10. Guo S.S., Wu X., Shimoide A.T., Wong J., Moatamed F., and Sawicki M.P. Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours. J. Endocrinol. 179 (2003) 73-79
11. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
12. Heppner C., Bilimoria K.Y., Agarwal S.K., Kester M., Whitty L.J., Guru S.C., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Marx S.J., and Burns A.L. The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 (2001) 4917-4925
13. Hervieu V., Lepinasse F., Gouysse G., Guillaud O., Barel C., Chambonniere M.L., Bringuier P.P., Poncet G., Lombard-Bohas C., Partensky C., Chayvialle J.A., and Scoazec J.Y. Expression of beta-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases. J. Clin. Pathol. 59 (2006) 1300-1304
14. Ikeo Y., Sakurai A., Suzuki R., Zhang M.X., Koizumi S., Takeuchi Y., Yumita W., Nakayama J., and Hashizume K. Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: possible role of the menin as a negative regulator of cell proliferation under DNA damage. Lab. Invest. 80 (2000) 797-804
15. Imanishi Y., Hosokawa Y., Yoshimoto K., Schipani E., Mallya S., Papanikolaou A., Kifor O., Tokura T., Sablosky M., Ledgard F., Gronowicz G., Wang T.C., Schmidt E.V., Hall C., Brown E.M., Bronson R., and Arnold A. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J. Clin. Invest. 107 (2001) 1093-1102
16. Inan M.S., Tolmacheva V., Wang Q.S., Rosenberg D.W., and Giardina C. Transcription factor NF-κB participates in regulation of epithelial cell turnover in the colon. Am. J. Physiol. 279 (2000) G1282-G1291
17. Karnik S.K., Hughes C.M., Gu X., Rozenblatt-Rosen O., McLean G.W., Xiong Y., Meyerson M., and Kim S.K. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14659-14664
18. Kim Y.S., Burns A.L., Goldsmith P.K., Heppner C., Park S.Y., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., and Marx S.J. Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18 (1999) 5936-5942
19. Kim H.J., Hawke N., and Baldwin A.S. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 13 (2006) 738-747
20. Kishida Y., Yoshikawa H., and Myoui A. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin. Cancer Res. 13 (2007) 59-67
21. Libutti S.K., Crabtree J.S., Lorang D., Burns A.L., Mazzanti C., Hewitt S.M., O'Connor S., Ward J.M., Emmert-Buck M.R., Remaley A., Miller M., Turner E., Alexander H.R., Arnold A., Marx S.J., Collins F.S., and Spiegel A.M. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res. 63 (2003) 8022-8028
22. Lin Y.G., Kunnumakkara A.B., Nair A., Merritt W.M., Han L.Y., Armaiz-Pena G.N., Kamat A.A., Spannuth W.A., Gershenson D.M., Lutgendorf S.K., Aggarwal B.B., and Sood A.K. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin. Cancer Res. 13 (2007) 3423-3430
23. Mallya S.M., and Arnold A. Cyclin D1 in parathyroid disease. Front Biosci. 5 (2000) D367-D371
24. Marín Y.E., Wall B.A., Wang S., Namkoong J., Martino J.J., Suh J., Lee H.J., Rabson A.B., Yang C.S., Chen S., and Ryu J.H. Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. 17 (2007) 274-283
25. Milne T.A., Hughes C.M., Lloyd R., Yang Z., Rozenblatt-Rosen O., Dou Y., Schnepp R.W., Krankel C., Livolsi V.A., Gibbs D., Hua X., Roeder R.G., Meyerson M., and Hess J.L. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 749-754
26. Oka D., Nishimura K., Shiba M., Nakai Y., Arai Y., Nakayama M., Takayama H., Inoue H., Okuyama A., and Nonomura N. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-κB. Int. J. Cancer 120 (2007) 2576-2581
27. Ratineau C., Bernard C., Poncet G., Blanc M., Josso C., Fontanière S., Calender A., Chayvialle J.A., Zhang C.X., and Roche C. Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. J. Biol. Chem. 279 (2004) 24477-24484
28. Rosenberg C.L., Kim H.G., Shows T.B., Kronenberg H.M., and Arnold A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9638-9642
29. Schnepp R.W., Mao H., Sykes S.M., Zong W.X., Silva A., La P., and Hua X. Menin induces apoptosis in murine embryonic fibroblasts. J. Biol. Chem. 279 (2004) 10685-10691
30. Schnepp R.W., Chen Y.X., Wang H., Cash T., Silva A., Diehl J.A., Brown E., and Hua X. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells. Cancer Res. 66 (2006) 5707-5715
31. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5522-5527
32. Yang Y., and Hua X. In search of tumor suppressing functions of menin. Mol. Cell. Endocrinol. 265/266 (2007) 34-41